Expression levels of matrix metalloproteinase-9 in human gastric carcinoma

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 915-919

  Chen, Su Zuan ^a   Yao, Huai Qi ^a   Zhu, Sen Zhi ^a   Li, Qiu Yuan ^a   Guo, Guang Hua ^a   Yu, Jing ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Gastric carcinoma; Immunohistochemistry; Malignancy; Matrix metalloproteinases 9; Semi quantitative polymerase chain reaction

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PREOPERATIVE CARE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

EID: 84918786824     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2768     Document Type: Article

References (27)

1. Wei F, Huang P, Li S, et al: Enhancement patterns of gastric carcinoma on contrast-enhanced ultrasonography: relationship with clinicopathological features. PLoS One 8: e73050, 2013.
2. Paz H, Pathak N and Yang J: Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene 33: 4193-4202, 2014.
3. Iizasa T, Fujisawa T, Suzuki M, et al: Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 5: 149-153, 1999.
4. Hofmann UB, Westphal JR, Van Muijen GN and Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest Dermatol 115: 337-344, 2000.
5. Westermarck J and Kähäri VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
6. Tan SY, Wang JY, Shen L, Luo HS and Shen ZX: Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma. World J Gastroenterol 13: 2108-2112, 2007.
7. Ylisirniö S, Höyhtyä M and Turpeenniemi-Hujanen T: Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer -TIMP-1 as a prognostic marker. Anticancer Res 20: 1311-1316, 2000.
8. Czyzewska J, Guzińska-Ustymowicz K, Kemona A and Bandurski R: The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival. Folia Histochem Cytobiol 46: 57-64, 2008.
9. Zheng H, Takahashi H, Murai Y, et al: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26: 3579-3583, 2006.
10. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
11. Peng SH, Deng H, Yang JF, et al: Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 11: 6521-6524, 2005.
12. Endo K, Maehara Y, Baba H, et al: Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res 17: 2253-2258, 1997.
13. Alakus H, Grass G, Hennecken JK, et al: Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol 23: 917-923, 2008.
14. Lee KH, Shin SJ, Kim KO, et al: Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep 16: 823-830, 2006.
15. Lee LY, Wu CM, Wang CC, et al: Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol 23: 515-521, 2008.
16. Papathoma AS, Petraki C, Grigorakis A, et al: Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer. Anticancer Res 20: 2009-2013, 2000.
17. Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH and Lee KB: Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 72: 166-175, 2005.
18. Torii A, Kodera Y, Uesaka K, et al: Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg 84: 133-136, 1997.
19. Unemori EN, Hibbs MS and Amento EP: Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88: 1656-1662, 1991.
20. Creemers EE, Cleutjens JP, Smits JF and Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89: 201-210, 2001.
21. Herman MP, Sukhova GK, Libby P, et al: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104: 1899-1904, 2001.
22. Bergin PJ, Raghavan S, Svensson H, et al: Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. FEMS Immunol Med Microbiol 52: 88-98, 2008.
23. Wu CY, Wu MS, Chiang EP, et al: Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res 13: 2054-2060, 2007.
24. Dragutinović VV, Radovanović NS, Izrael-Zivković LT and Vrvić MM: Detection of gelatinase B activity in serum of gastric cancer patients. World J Gastroenterol 12: 105-109, 2006.
25. Gerlach RF, Uzuelli JA, Souza-Tarla CD and Tanus-Santos JE: Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 344: 147-149, 2005.
26. Laack E, Scheffler A, Burkholder I, et al: Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer 50: 51-58, 2005.
27. Shimanuki Y, Takahashi K, Cui R, et al: Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer. Lung 183: 29-42, 2005.